Magnetic Resonance Imaging (MRI) to Predict Outcomes of Pancreatic Ductal Adenocarcinoma (PDAC)

NCT04700488 · clinicaltrials.gov ↗
NA
Phase
SUSPENDED
Status
36
Enrollment
OTHER
Sponsor class

Stopped Cedars-Sinai Cancer Center Protocol Review and Monitoring Committee has requested several protocol modifications and clarifications regarding study outcomes and completion of data entry for subjects who exited the study. Changes are in the process.

Conditions

Interventions

Sponsor

Cedars-Sinai Medical Center